HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Herman Hamersma Selected Research

Sclerosteosis

12/2011Patients with sclerosteosis and disease carriers: human models of the effect of sclerostin on bone turnover.
12/2005Bone mineral density in sclerosteosis; affected individuals and gene carriers.
11/2005Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Herman Hamersma Research Topics

Disease

3Sclerosteosis
12/2011 - 11/2005
2Osteoporosis
12/2005 - 10/2004
1Facial Paralysis (Facial Palsy)
01/2007
1Osteochondrodysplasias (Spondyloepiphyseal Dysplasia)
06/2002

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
12/2005 - 11/2005
1collagen type I trimeric cross-linked peptideIBA
12/2011
1ProcollagenIBA
12/2011
1Pharmaceutical PreparationsIBA
10/2004
1Intergenic DNA (Junk DNA)IBA
06/2002

Therapy/Procedure

1Decompression
01/2007
1Therapeutics
12/2005